You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
In vitro Models Suitable for High-throughput Screening of Drug Toxicities in Human Tissues
SBC: Nico Technologies Corp. Topic: CBD10103The drug R&D cycle is long and very expensive. In many ways, this status quo can no longer be sustained. One of the reasons for such great cost is that the vast majority of drug candidates are screened out at the stages of animal and human trials. More efficient methods of testing of drugs at the stage of ex-vivo studies, which are substantially less expensive than animal and human testing cyc ...
SBIR Phase I 2010 Department of DefenseOffice for Chemical and Biological Defense -
Multifunctional Antisense Therapeutics Nanocarrier and Inhalation Device
SBC: Physical Optics Corporation Topic: CBD10102To address the CBD need for improved formulations to enhance the ease of use and bioavailability of antisense therapeutics, Physical Optics Corporation (POC) proposes to develop a Multifunctional Antisense Therapeutics Nanocarrier and Inhalation Device (MATEN). This proposed system is based on a new dry powder formulation and a novel design of an inhaler that uses in-house developed mature compone ...
SBIR Phase I 2010 Department of DefenseOffice for Chemical and Biological Defense -
Miniature Residual Life Indicator
SBC: Physical Optics Corporation Topic: CBD10106Impregnated ASZM-TEDA carbon employed as highly adsorptive materials in Collective Protection (ColPro) systems loses the ability to adsorb toxic chemicals because of exposure to temperature, humidity, battlefield contaminants, and other pollutants. To address the Chemical and Biological Defense (CBD) need for a residual life indicator (RLI) capable of probing the degradation in physical adsorption ...
SBIR Phase I 2010 Department of DefenseOffice for Chemical and Biological Defense -
3D Microfluidic Platform for in vitro Hematopoietic Stem Cell (HSC) Culture
SBC: Physical Optics Corporation Topic: CBD10103To address the Chemical/Bio Defense (CBD) need for in vitro models suitable for high-throughput screening of drug toxicities in human tissues, Physical Optics Corporation (POC) proposes to develop a new three-dimensional (3D) Microfluidic Platform for in-vitro Hematopoietic Stem Cell (HSC) Culture (3D-Mic-Stem). This proposed system is based on a 3D microfluidic design that uses HSCs for assaying ...
SBIR Phase I 2010 Department of DefenseOffice for Chemical and Biological Defense -
Microfluidic Dielectrophoretic Screening System
SBC: Physical Optics Corporation Topic: CBD10107To address the U.S. Army/DTRA’s CBD program need for a robust screening process for use with large panels of enzymes to identify variants with higher affinity for organophosphorus (OP) substrates, Physical Optics Corporation (POC) proposes to develop a Microfluidic Dielectrophoretic Screening (MDS) system. This proposed system is based on the new design of a microfluidic mixer, enzymatic reactor ...
SBIR Phase I 2010 Department of DefenseOffice for Chemical and Biological Defense -
Ultrafast Gas Curtain and Wire-Reinforced X-Ray Window Debris Shields
SBC: ALAMEDA APPLIED SCIENCES CORPORATION Topic: N/AAlameda Applied Sciences Corporation (AASC) proposes to develop two components of a three-component, survivable debris shield for large area test exposures to cold (1-5keV) x-rays. These elements also have commercial potential in accelerators and in radiography. The elements are: an ultrafast gas curtain designed to be located close to the x-ray source to deflect plasma debris as well as ~um siz ...
SBIR Phase I 1998 Department of DefenseNational Geospatial-Intelligence Agency -
Lightweight Biosensor Badge to Monitor Environmental Organophosphates
SBC: ADVANCED SENSOR TECHNOLOGIES, INC. Topic: N/A"The US Joint Services, Federal Agencies, and state and local First Responders have expressed dissatisfaction with currently employed organophosphate (OP) sensors. They have identified the need for a new generation of sensors that is small, light-weight,and easy to use while being capable of extended operations in rugged environments. Advanced Sensor Technologies proposes to address these issues w ...
SBIR Phase I 2002 Department of DefenseOffice for Chemical and Biological Defense -
Handheld IR Raman Spectroscopy for Rapid Chemical Identification
SBC: Aerius Photonics, LLC. Topic: CBD08102Aerius Photonics and partner Ahura Scientific, propose to develop a handheld system, based on Ahura’s successful FirstDefender Raman system, that employs an excitation laser emitting at 980 nm and a low noise InGaAs array based on Aerius’ high performance InGaAs technology. This system will substantially reduce the fluorescence present in CCD-based systems, and unmask otherwise obscured spect ...
SBIR Phase I 2008 Department of DefenseOffice for Chemical and Biological Defense -
Passive multi-view, multi-channel detection of highly obscured targets
SBC: Arete Associates Topic: NGA04001The goal of this Phase I SBIR is to define a set of algorithms that will detect and characterize static man-made objects highly obscured by foliage within multi-view, multi-channel optical data collected passively from UAVs or other aerial platforms. The proposed algorithm stream will be constructed so as to comprehend and mitigate real-world interfering effects such as clouds, smoke and haze. Dur ...
SBIR Phase I 2004 Department of DefenseNational Geospatial-Intelligence Agency -
Automated Rational Design of Antibodies
SBC: BIOREN Topic: CBD04105Bioren's technology provides an efficient, automated, in vitro system to generate and optimize antibodies and antibody fragments through a rational, hypothesis-driven approach. Bioren's patented technology is based on synthetic oligonucleotide chemistry to create defined antibody mutations. Hypotheses regarding the impact of a specific amino acid's side-chain chemistry within the antigen binding ...
SBIR Phase I 2004 Department of DefenseOffice for Chemical and Biological Defense